H
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
Price:
3.68
CNY
-0.81%
Market Closed
Market Cap:
¥7.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
|
CN |
|
Seadrill Ltd
OSE:SDRL
|
BM |
|
A
|
Adecco Group AG
LSE:0QNM
|
CH |
|
R
|
ReTo Eco-Solutions Inc
NASDAQ:RETO
|
CN |
|
A
|
Autodesk Inc
BMV:ADSK
|
US |
|
Arcadyan Technology Corp
TWSE:3596
|
TW |
|
Aqua Metals Inc
NASDAQ:AQMS
|
US |
|
Wuxi Lihu Corporation Limited
SZSE:300694
|
CN |
|
Gansu Yatai Industrial Development Co Ltd
SZSE:000691
|
CN |
|
G
|
G.M.I Technology Inc
TWSE:3312
|
TW |
|
MotorCycle Holdings Ltd
ASX:MTO
|
AU |
|
Lundin Mining Corp
TSX:LUN
|
CA |
Wall Street
Price Targets
Price Targets Summary
Hunan Er-Kang Pharmaceutical Co Ltd
Hunan Er-Kang Pharmaceutical Co Ltd
There are no price targets for Hunan Er-Kang Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hunan Er-Kang Pharmaceutical Co Ltd's stock price target?
Not Available
Hunan Er-Kang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hunan Er-Kang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%
10%
For the last 13 years the compound annual growth rate for Hunan Er-Kang Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 8 years is 10%.
